JP2018535932A5 - - Google Patents

Info

Publication number

JP2018535932A5

JP2018535932A5 JP2018516668A JP2018516668A JP2018535932A5 JP 2018535932 A5 JP2018535932 A5 JP 2018535932A5 JP 2018516668 A JP2018516668 A JP 2018516668A JP 2018516668 A JP2018516668 A JP 2018516668A JP 2018535932 A5 JP2018535932 A5 JP 2018535932A5

Authority

JP

Japan

Prior art keywords

antibody

adme

binding

chain

seq

Prior art date

2016-09-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 230000001105 regulatory effect Effects 0.000 claims description 45
• 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 claims description 41
• 102100029571 Immunoglobulin J chain Human genes 0.000 claims description 41
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 26
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 26
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
• 239000012634 fragment Substances 0.000 claims description 10
• 102000009027 Albumins Human genes 0.000 claims description 8
• 108010088751 Albumins Proteins 0.000 claims description 8
• 239000000427 antigen Substances 0.000 claims description 8
• 102000036639 antigens Human genes 0.000 claims description 8
• 108091007433 antigens Proteins 0.000 claims description 8
• 239000003937 drug carrier Substances 0.000 claims description 8
• 239000008194 pharmaceutical composition Substances 0.000 claims description 8
• 102000004190 Enzymes Human genes 0.000 claims description 6
• 108090000790 Enzymes Proteins 0.000 claims description 6
• 206010028980 Neoplasm Diseases 0.000 claims description 6
• 201000011510 cancer Diseases 0.000 claims description 6
• 102000004338 Transferrin Human genes 0.000 claims description 5
• 108090000901 Transferrin Proteins 0.000 claims description 5
• 102100032807 Tumor necrosis factor-inducible gene 6 protein Human genes 0.000 claims description 5
• 101710169430 Tumor necrosis factor-inducible gene 6 protein Proteins 0.000 claims description 5
• 239000000126 substance Substances 0.000 claims description 5
• JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical group O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 claims description 4
• 102000018866 Hyaluronan Receptors Human genes 0.000 claims description 4
• 108010013214 Hyaluronan Receptors Proteins 0.000 claims description 4
• 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 claims description 4
• 101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 claims description 4
• 102000005962 receptors Human genes 0.000 claims description 4
• 108020003175 receptors Proteins 0.000 claims description 4
• JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 claims description 4
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
• 102000038455 IGF Type 1 Receptor Human genes 0.000 claims description 3
• 108010031794 IGF Type 1 Receptor Proteins 0.000 claims description 3
• 102000003746 Insulin Receptor Human genes 0.000 claims description 3
• 108010001127 Insulin Receptor Proteins 0.000 claims description 3
• 102100031775 Leptin receptor Human genes 0.000 claims description 3
• 102000007238 Transferrin Receptors Human genes 0.000 claims description 3
• 108010033576 Transferrin Receptors Proteins 0.000 claims description 3
• 206010064930 age-related macular degeneration Diseases 0.000 claims description 3
• 229920002674 hyaluronan Polymers 0.000 claims description 3
• 229960003160 hyaluronic acid Drugs 0.000 claims description 3
• -1 imide esters Chemical class 0.000 claims description 3
• 108010019813 leptin receptors Proteins 0.000 claims description 3
• 239000003446 ligand Substances 0.000 claims description 3
• 208000002780 macular degeneration Diseases 0.000 claims description 3
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
• 239000012581 transferrin Substances 0.000 claims description 3
• 102000016267 Leptin Human genes 0.000 claims description 2
• 108010092277 Leptin Proteins 0.000 claims description 2
• 150000001299 aldehydes Chemical class 0.000 claims description 2
• 230000001588 bifunctional effect Effects 0.000 claims description 2
• 210000003169 central nervous system Anatomy 0.000 claims description 2
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 2
• 238000001212 derivatisation Methods 0.000 claims description 2
• 125000005442 diisocyanate group Chemical group 0.000 claims description 2
• 150000002148 esters Chemical class 0.000 claims description 2
• 150000002222 fluorine compounds Chemical class 0.000 claims description 2
• 230000013595 glycosylation Effects 0.000 claims description 2
• 238000006206 glycosylation reaction Methods 0.000 claims description 2
• 238000003780 insertion Methods 0.000 claims description 2
• 230000037431 insertion Effects 0.000 claims description 2
• 230000014759 maintenance of location Effects 0.000 claims description 2
• 230000001323 posttranslational effect Effects 0.000 claims description 2
• 235000018102 proteins Nutrition 0.000 claims description 2
• 102000004169 proteins and genes Human genes 0.000 claims description 2
• 108090000623 proteins and genes Proteins 0.000 claims description 2
• CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical compound N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 claims description 2
• 230000004048 modification Effects 0.000 claims 4
• 238000012986 modification Methods 0.000 claims 4
• 125000003275 alpha amino acid group Chemical group 0.000 claims 3
• 239000000178 monomer Substances 0.000 claims 2
• 238000010521 absorption reaction Methods 0.000 claims 1
• 239000000539 dimer Substances 0.000 claims 1
• 230000029142 excretion Effects 0.000 claims 1
• 230000004060 metabolic process Effects 0.000 claims 1
• 230000035502 ADME Effects 0.000 description 41
• 239000003814 drug Substances 0.000 description 7
• 150000001413 amino acids Chemical class 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 5
• 208000024827 Alzheimer disease Diseases 0.000 description 4
• 235000001014 amino acid Nutrition 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 102100021257 Beta-secretase 1 Human genes 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 201000007455 central nervous system cancer Diseases 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 230000031998 transcytosis Effects 0.000 description 2
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
• 101710150192 Beta-secretase 1 Proteins 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 208000005890 Neuroma Diseases 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 229910052731 fluorine Inorganic materials 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 230000002489 hematologic effect Effects 0.000 description 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
• 108091008039 hormone receptors Proteins 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 206010027191 meningioma Diseases 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 208000022679 triple-negative breast carcinoma Diseases 0.000 description 1
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1